A lack of antibody formation against inactivated influenza virus after aerosol vaccination in presence or absence of adjuvantia

Veterinary Immunology and Immunopathology

Volumn 143, Issue 1-2, 2011, Pages 143-147

  De Geus, Eveline D ^a   Van Haarlem, Daphne A ^a   Poetri, Okti N ^a   De Wit, J J Sjaak ^b   Vervelde, Lonneke ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GD ANIMAL HEALTH   (Netherlands)

Author keywords

Adjuvant; Aerosol vaccination; Avian influenza virus; Inactivated vaccine; Mucosa; WIV

Indexed keywords

ALUMINUM HYDROXIDE; ANTIBODY; AVIAN INFLUENZA VACCINE; BETA GLUCAN; CHITOSAN; CHOLERA TOXIN B SUBUNIT; INACTIVATED VACCINE; NOVAMATRIX; PROTASAN; STIMUNE; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AVIAN INFLUENZA VIRUS; CHICKEN; CONTROLLED STUDY; DRUG MEGADOSE; EPIDEMIC; FEMALE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H9N2; LOW DRUG DOSE; MALE; MASS APPLICATION; NONHUMAN; POULTRY; RESPIRATORY SYSTEM; RISK; VACCINATION; WEIGHT GAIN;

ADJUVANTS, IMMUNOLOGIC; AEROSOLS; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CHITOSAN; CHOLERA TOXIN; FEMALE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MALE; RESPIRATORY SYSTEM; VACCINES, INACTIVATED;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 79961028993     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.05.023     Document Type: Article

References (34)

1. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 8:725-731.
2. Atmar R.L., Keitel W.A., Cate T.R., Munoz F.M., Ruben F., Couch R.B. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine 2007, 29:5367-5373.
3. Bacon A., Makin J., Sizer P.J., Jabbal-Gill I., Hinchcliffe M., Illum L., Chatfield S., Roberts M. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect. Immun. 2000, 68(10):5764-5770.
4. Chang H., Li X., Teng Y., Liang Y., Peng B., Fang F., Chen Z. Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine. DNA Cell Biol. 2010, 9:563-568.
5. Corbanie E.A., Matthijs M.G., van Eck J.H., Remon J.P., Landman W.J., Vervaet C. Deposition of differently sized airborne microspheres in the respiratory tract of chickens. Avian Pathol. 2006, 6:475-485.
6. Corbanie E.A., Vervaet C., van Eck J.H., Remon J.P., Landman W.J. Vaccination of broiler chickens with dispersed dry powder vaccines as an alternative for liquid spray and aerosol vaccination. Vaccine 2008, 35:4469-4476.
7. Cornelissen L.A., de Vries R.P., de Boer-Luijtze E.A., Rigter A., Rottier P.J., de Haan C.A. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 2010, 5:e10645.
8. De Wit J.J., Swart W.A., Fabri T.H. Efficacy of infectious bronchitis virus vaccinations in the field: association between the alpha-IBV IgM response, protection and vaccine application parameters. Avian Pathol. 2010, 2:123-131.
9. Fedde M.R., Weigle G.E., Wideman R.F. Influence of feed deprivation on ventilation and gas exchange in broilers: relationship to pulmonary hypertension syndrome. Poult. Sci. 1998, 11:1704-1710.
10. Hagenaars N., Mastrobattista E., Glansbeek H., Heldens J., van den Bosch H., Schijns V., Betbeder D., Vromans H., Jiskoot W. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Vaccine 2008, 26:6555-6563.
11. Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., Takahashi H., Sawa H., Chiba J., Kurata T., Sata T., Hasegawa H. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J. Virol. 2005, 5:2910-2919.
12. Ichinohe T., Watanabe I., Tao E., Ito S., Kawaguchi A., Tamura S., Takahashi H., Sawa H., Moriyama M., Chiba J., Komase K., Suzuki Y., Kurata T., Sata T., Hasegawa H. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant. J. Med. Virol. 2006, 7:954-963.
13. Joo H.M., He Y., Sundararajan A., Huan L., Sangster M.Y. Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination. Vaccine 2010, 10:2186-2194.
14. Lambrecht B.N., Kool M., Willart M.A., Hammad H. Mechanism of action of clinically approved adjuvants. Curr. Opin. Immunol. 2009, 1:23-29.
15. Ley D.H. Mycoplasmosis. Diseases of Poultry 2003, 722-744. Iowa State University Press. Y.M. Saif, H.J. Barnes, J.R. Glission, A.M. Fadly, L.R. McDougald, D.E. Swayne (Eds.).
16. Maas R., Tacken M., van Zoelen D., Oei H. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion. Vaccine 2009, 27:3592-3597.
17. Matsuo K., Yoshikawa T., Asanuma H., Iwasaki T., Hagiwara Y., Chen Z., Kadowaki S.E., Tsujimoto H., Kurata T., Tamura S.I. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). Vaccine 2000, 24:2713-2722.
18. Nicholson K.G., Thompson C.I., Klap J.M., Wood J.M., Batham S., Newman R.W., Mischler R., Zambon M.C., Stephenson I. Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations. Vaccine 2009, 1:171-178.
19. Rauw F., Gardin Y., Palya V., Anbari S., Gonze M., Lemaire S., van den Berg T., Lambrecht B. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet. Immunol. Immunopathol. 2010, 134:249-258.
20. Read R.C., Naylor S.C., Potter C.W., Bond J., Jabbal-Gill I., Fisher A., Illum L., Jennings R. Effective nasal influenza vaccine delivery using chitosan. Vaccine 2005, 35:4367-4374.
21. Rebel J.M., Peeters B., Fijten H., Post J., Cornelissen J., Vervelde L. Highly pathogenic or low pathogenic avian influenza virus subtype H7N1 infection in chicken lungs: small differences in general acute responses. Vet. Res. 2011, 1:10-20.
22. Reemers S.S., van Haarlem D.A., Groot Koerkamp M.J., Vervelde L. Differential gene-expression and host-response profiles against avian influenza virus within the chicken lung due to anatomy and airflow. J. Gen. Virol. 2009, 9:2134-2146.
23. Reemers S.S., Jansen C., Koerkamp M.J., van Haarlem D., van de Haar P., Degen W.G., van Eden W., Vervelde L. Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: a transcriptomics analysis of adjuvanted vaccines. Vaccine 2010, 38:6351-6360.
24. Takada A., Kida H. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet. Microbiol. 1996, 1-2:17-25.
25. Saluja V., Amorij J.P., van Roosmalen M.L., Leenhouts K., Huckriede A., Hinrichs W.L., Frijlink H.W. Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant. AAPS J. 2010, 2:109-116.
26. Stok W., van der Heijden P.J., Bianchi A.T. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit. Vaccine 1994, 6:521-526.
27. Sui Z., Chen Q., Wu R., Zhang H., Zheng M., Wang H., Chen Z. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Arch. Virol. 2010, 4:535-544.
28. Sui Z., Chen Q., Fang F., Zheng M., Chen Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010, 28:7690-7698.
29. Toro H., van Ginkel F.W., Tang D.C., Schemera B., Rodning S., Newton J. Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5. Avian Dis. 2010, 54:224-231.
30. Tseng L.P., Chiou C.J., Chen C.C., Deng M.C., Chung T.W., Huang Y.Y., Liu D.Z. Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens. Vet. Immunol. Immunopathol. 2009, 3-4:285-289.
31. Vervelde L., Janse E.M., Vermeulen A.N., Jeurissen S.H. Induction of a local and systemic immune response using cholera toxin as vehicle to deliver antigen in the lamina propria of the chicken intestine. Vet. Immunol. Immunopathol. 1998, 3:261-272.
32. Worrall E.E., Sudarisman, Priadi A. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry. Vaccine 2009, 31:4161-4168.
33. Yoshikawa T., Matsuo K., Matsuo K., Suzuki Y., Nomoto A., Tamura S., Kurata T., Sata T. Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice. J. Gen. Virol. 2004, 8:2339-2346.
34. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., Zhang X.F., Pan H.X., Meng F.Y., Hu Y.M., Liu W.D., Li C.G., Li W., Zhang X., Hu J.M., Peng W.B., Yang B.P., Xi P., Wang H.Q., Zheng J.S. A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med. 2009, 25:2414-2423.